Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Balance Sheet
Balance Sheet Decomposition
Rhythm Pharmaceuticals Inc
Current Assets | 235.8m |
Cash & Short-Term Investments | 201.2m |
Receivables | 14.7m |
Other Current Assets | 19.9m |
Non-Current Assets | 22.9m |
PP&E | 1.8m |
Intangibles | 6.8m |
Other Non-Current Assets | 14.3m |
Current Liabilities | 54.2m |
Accounts Payable | 7.6m |
Accrued Liabilities | 35.2m |
Other Current Liabilities | 11.4m |
Non-Current Liabilities | 142.9m |
Long-Term Debt | 107.4m |
Other Non-Current Liabilities | 35.5m |
Balance Sheet
Rhythm Pharmaceuticals Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
0
|
35
|
7
|
34
|
50
|
62
|
101
|
59
|
128
|
60
|
|
Cash Equivalents |
0
|
35
|
7
|
34
|
50
|
62
|
101
|
59
|
128
|
60
|
|
Short-Term Investments |
0
|
0
|
4
|
114
|
203
|
230
|
72
|
236
|
206
|
216
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
15
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
15
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
9
|
|
Other Current Assets |
0
|
1
|
1
|
3
|
7
|
10
|
9
|
13
|
12
|
9
|
|
Total Current Assets |
0
|
36
|
11
|
151
|
259
|
302
|
182
|
308
|
354
|
308
|
|
PP&E Net |
0
|
0
|
1
|
1
|
1
|
6
|
5
|
4
|
3
|
2
|
|
PP&E Gross |
0
|
0
|
1
|
1
|
1
|
6
|
5
|
4
|
3
|
2
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
4
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
8
|
7
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
12
|
17
|
15
|
|
Total Assets |
0
N/A
|
37
+18 550%
|
12
-67%
|
152
+1 133%
|
260
+72%
|
309
+19%
|
187
-39%
|
330
+76%
|
383
+16%
|
333
-13%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
1
|
2
|
2
|
8
|
10
|
5
|
6
|
5
|
5
|
|
Accrued Liabilities |
0
|
3
|
3
|
4
|
6
|
14
|
13
|
31
|
34
|
40
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
7
|
1
|
11
|
|
Total Current Liabilities |
1
|
5
|
5
|
7
|
14
|
24
|
18
|
43
|
40
|
55
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
76
|
106
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
2
|
3
|
2
|
|
Total Liabilities |
1
N/A
|
5
+783%
|
5
-6%
|
7
+38%
|
14
+103%
|
28
+96%
|
21
-25%
|
45
+121%
|
118
+160%
|
163
+38%
|
|
Equity | |||||||||||
Common Stock |
0
|
40
|
40
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
40
|
51
|
77
|
110
|
185
|
325
|
459
|
529
|
710
|
895
|
|
Additional Paid In Capital |
39
|
43
|
44
|
255
|
431
|
606
|
626
|
813
|
974
|
1 064
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
0
N/A
|
32
N/A
|
7
-77%
|
145
+1 884%
|
246
+70%
|
281
+14%
|
167
-41%
|
284
+71%
|
264
-7%
|
170
-36%
|
|
Total Liabilities & Equity |
0
N/A
|
37
+18 550%
|
12
-67%
|
152
+1 133%
|
260
+72%
|
309
+19%
|
187
-39%
|
330
+76%
|
383
+16%
|
333
-13%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
26
|
26
|
26
|
27
|
34
|
44
|
44
|
50
|
57
|
59
|